View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Pierre FerraguÊ
  • Pierre FerraguÊ

Tariffs – How would a recession affect our coverage?

The tariffs announced by the Trump administration in the last two weeks have resulted in major swings in the stock market and broader concerns regarding the global economy. We developed a framework to understand the situation and interpret its daily evolution last week and follow up today with an initial perspective on potential macro implications.

Daniel Ives ... (+3)
  • Daniel Ives
  • Sam Brandeis
  • Scott Devitt

Samsung Electronics: 1 director

A director at Samsung Electronics sold 667 shares at 53,700.000KRW and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Dan Salmon
  • Dan Salmon

Alphabet (GOOGL, Buy, $220 target) Google Cloud Next: Implications of...

The most important announcement so far was the launch of TPUv7 Ironwood. Though not a big surprise, the performance improvements are meaningful (more details below) and we continue to model 450K coming online this year, though there could be upside to this considering they are expected to be generally available later this year.

Daniel Ives ... (+5)
  • Daniel Ives
  • Matthew Weiss
  • Sam Brandeis
  • Scott Devitt
  • Steven Wahrhaftig
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch